Modern algorithms for the diagnosis and treatment of transient ischaemic attacks
https://doi.org/10.30629/0023-2149-2021-99-2-85-90
Abstract
The article analyzes the current tendencies in the diagnosis and treatment of transient ischaemic attacks (TIA). The prevalence of TIA in the population has not been established due to the uncertainty of the diagnostic criteria. The authors discuss the problem of a qualitative diagnosis of TIA in detail. Based on the current clinical recommendations, modern and promising methods of treatment are discussed. The authors pay special attention to the assessment of the risk of bleeding during aggressive antithrombotic therapy.
About the Authors
E. A. Shirokov
Military Medical Academy named after Kirov S.M. (Moscow Branch) of the Ministry of Defense of Russia
Russian Federation
Russian Federation
Evgenii A. Shirocon — MD, PhD, DSc, professor, professor of the department of emergency medicine
107392, Moscow
V. L. Glatko
Military Medical Academy named after Kirov S.M. (Moscow Branch) of the Ministry of Defense of Russia
Russian Federation
Russian Federation
107392, Moscow
O. A. Sapronenkova
Military Medical Academy named after Kirov S.M. (Moscow Branch) of the Ministry of Defense of Russia
Russian Federation
Russian Federation
107392, Moscow
References
1. Amarenco P., Lavallée C., Monteiro Tavares L. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. New Engl. J. Med. 2018;378(23):2182–2190. Published online 2018 May 16. DOI: 10.1056/NEJMoa1802712
2. Uchiyama S., Amarenco P., Minematsu K. et al. TIA as Acute Cerebrovascular Syndrome. Front. Neurol. Neurosci. Basel, Karger. 2014;33:35–146. DOI: 10.1159/000351914
3. Shahjouei S., Sadighi A., Chaudhary D. et al. A 5-Decade Analysis of Incidence Trends of Ischemic Stroke After Transient Ischemic Attack. A Systematic Review and Meta-analysis. JAMA Neurol. 2021;78(1):77–87. DOI: 10.1001/jamaneurol.2020.3627
4. Dolmans L.S., Hoes A., Bartelink E. et al. Patient delay in TIA: a systematic review. Jornal of Neurology. 2019;266(5):1051–1058. DOI: 10.1007/s00415-018-8977-6
5. Lebedeva E.R., Gurary N.M., Olesen E. Diagnostic criteria for transient ischemic attack. Neurology, neuropsychiatry, psychosomatics. 2018;10(2):12– 19. (in Russian)
6. Paul N., Rothwell P. Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study. Lancet Neurol. 2013;12:65–71.
7. Stroke foundation of New Zealand. New Zealand guideline for the assessment and management of people with recent transient ischaemic attack (TIA). 2008. [Electronic resource]. URL: www.stroke.org.nz (accessed 2011 May 3).
8. The Stroke Prevention and Educational Awareness Diff usion (SPREAD) Collaboration. The Italian guidelines for stroke prevention. Neurol. Sci. 2006;21:5–12.
9. Special report from the National Institute of Neurological Disorders and Stroke. Classifi cation of cerebrovascular diseases III. Stroke. 1990;21(4):637–76. DOI: 10.1161/01.str.21.4.637
10. Shirokov E.A., Simonenko V.B., Ovchinnikov Yu.V. Transient ischemic attacks and small strokes: modern therapeutic strategies. Lechasyi vrach. 2020; 5:7–11. (in Russian)
11. Lioutas V., Ivan C., Himali J. et al. Incidence of Transient Ischemic Attack and Association With Long-term Risk of Stroke. JAMA. 2021;325(4):373–381. DOI:10.1001/jama.2020.25071
12. Powers W., Rabinstein A., Ackerson T. et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3): e46-e110. DOI: 10.1161/STR.0000000000000158
13. Prasad K., Siemieniuk R., Hao Q. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. BMJ. 2018;363:k5130. DOI: 10.1136/bmj.k5130
14. Sandercock P., Counsell C., Tseng M.C., Cecconi E. Oral antiplatelet therapy for acute ischemic stroke. Cochrane Database of Systematic Reviews. 2014;2014(3):CD000029. DOI: 10.1002/14651858.CD000029.pub3
15. Li Z., Wang Y., Zhao X. et al. Treatment eff ect of clopidogrel plus aspirin within 12 hours of acute minor stroke or transient ischemic attack. J. Am. Heart. Assoc. 2016;5(3):e003038. DOI: 10/1161/JAHA.115.003038
16. Pan Y. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack. JAMA Neurol. 2019;76(12): 1466–1473. Published online 2019 August 19. DOI: 10.1001/jamaneurol.2019.2531
17. Dutta D. Diagnosis of TIA (DOT) score — design and validation of a new clinical diagnostic tool for transient ischaemic attack. BMC Neurology. 2016;16:20. DOI: 10.1186/s12883-016-0535-1
18. Giles M.F., Albers G.W., Amarenco P. et al. Early stroke risk and ABCD2 score performance in tissue- vs time-defi ned TIA: a multicenter study. Neurology. 2011;77:1222–8.
19. Amarenco P., Labreuche J., Lavallée P.C. Patients with transient ischemic attack with ABCD2 <4 can have similar 90-day stroke risk as patients with transient ischemic attack with ABCD2 ≥4. Stroke. 2012;43:863–5.
20. Buryakovskaya L.I., Lomakin N.V., Sumarokov A.B., Shirokov E.A. Effi ciency and safety of antithrombotic therapy. Scales and algorithms. Clinical recommendations for doctors. Moscow; NOB, 2019:170. (in Russian)
21. Uchiyama S. TIA as Acute Cerebrovascular Syndrome. J. Neurol. Disord. Stroke. 2017;5(1):1121–8.
22. Simonenko V.B., Shirokov E.A., Frolov V.M. Clinical crizology in cardioneurology. Manual for doctors. Moscow; QUORUM, 2013:291. (in Russian)
23. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA. 1998;279:1265–1272.
24. Martinez-Majander N., Ntaios G., LiuI Y.Y. et al. Rivaroxaban versus aspirin for secondary prevention of ischemic stroke in patients with cancer: a subgroup analysis of NAVIGATE ESUS randomized trial. Eur. J. Neurol. 2020;27(5):841–848. DOI: 10.1111/ene.14172. Published online 2020.
25. Huisa B.N., Raman R., Ernstrom K. et al. Alberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke. J. Stroke Cerbrovasc. Dis. 2010;19:475–479. DOI: 10/1016/j.jstrokecerebrovasdis.2010.03.003
26. Shirokov E.A. COVID-associated ischemic stroke. Klinicheskaja medicina. 2020; 98(5):375–377. (in Russian)
27. Chen Z.M., Sandercoch P., Pan H.C. et al. Indication for early aspirin use in acute ischemic stroke. A combined analysis of 40 000 randomized patients from the Chines Acute Stroke Trial and the International Stroke Trial. Stroke. 2000;31:1240–1249.
28. Lavallée P., Amarenco P. Stroke Subtypes and Interventional Studies for Transient Ischemic Attack. TIA as Acute Cerebrovascular Syndrome. Front. Neurol. Neurosci. Basel, Karger. 2014;33:135– 146. DOI: 10.1159/000351914
29. Kennedy J., Ryckborst K. et al. for the FASTER investigators: Fast Assessment of Stroke and Transient Ischemic Attack to prevent Early Recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol. 2007;6:961–969.
30. 2020 ESC Guidelines for the diagnosis and management of atrial fi brillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2021;42(5):373–498. DOI: 10.1093/eurheartj/ehaa612
31. Amarenco P. Transient Ischemic Attack. N. Engl. J. Med. 2020;382:1933–41. DOI: 10.1056/NEJMcp1908837
32. Pan Y., Elm J., Li H. et al. Outcomes Associated With ClopidogrelAspirin Use in Minor Stroke or Transient Ischemic Attack. A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and PlateletOriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. JAMA Neurol. 2019;76(12):1466–1473. DOI: 10.1001/jamaneurol.2019.2531
33. Johnston S., Amarenco P., M.D., Denison H. et al. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. N. Engl. J. Med. 2020;383:207–17. DOI: 10.1056/NEJMoa1916870
Review
For citations:
Shirokov E.A., Glatko V.L., Sapronenkova O.A. Modern algorithms for the diagnosis and treatment of transient ischaemic attacks. Clinical Medicine (Russian Journal). 2021;99(2):85-90. (In Russ.) https://doi.org/10.30629/0023-2149-2021-99-2-85-90
Views:
627
Email this article 